Revance Therapeutics Inc.

(RVNC) Trade

By |

Profile

Revance Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Contact Information

Website: www.revance.com
Main Phone: +1 510 742-3400
Address: 7555 Gateway Boulevard
State: CA
City / Town: Newark
Country: USA
Postal Code: 94560

Issuer Information

Exchange: NSD
Employees: 108
NAICS: Pharmaceutical P
$ 23.45 $ -0.3 (-1.26%)
Last Price 23.45 Change $ -0.3 Change % -1.26 Tick N/A
Bid 22.25 Bid Size 500.00 Ask 27.90 Ask Size 100.00
Open 23.65 High 24.10 Low 23.35 Prev Close 23.75
Last Trade Volume 141,261 52 Wk Hi 28.30 52 Wk Low 12.35
Market Cap 722.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 30,819,189.00 EPS (TTM) -3.44 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 36
Number of Buys 3 19
Number of Sells 1 17
Net Activity 1415 74034
Last 10 Buys Shares
L. Daniel Browne 1,000
Last 10 Sell Shares
Curtis Ruegg 1,000
Curtis Ruegg 1,000
Curtis Ruegg 1,000
Curtis Ruegg 1,000
Curtis Ruegg 1,000
Curtis Ruegg 1,000
Arthur Peter Bertolino 1,000
Arthur Peter Bertolino 1,000
Arthur Peter Bertolino 1,000
Arthur Peter Bertolino 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 55 55 55 55
Low Target Price Estimate 22 22 22 22
Mean Target Price Estimate 42.5 42.5 42.67 42.5
Standard Deviation 12.85 12.85 12.82 12.85
Date of Most Recent Estimate 08/04/16 08/04/16 06/23/16 08/12/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 6
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1